IBALGIN
LIVE
Serial Number
79428778
Owner
Opella Healthcare Group SASAttorney
Jonathan M. RixenFiling Date
Jun 16, 2025
IBALGIN Trademark
Serial Number: 79428778
IBALGIN is a trademark filed by
Opella Healthcare Group SAS
on June 16, 2025. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jonathan M. Rixen Dennemeyer & Associates, LLC
230 W. Monroe St.
Suite 2100
Chicago, IL 60606
United States
Trademark Details
Filing Date
June 16, 2025
Registration Date
Not Registered
Published for Opposition
February 3, 2026
Goods & Services
Pharmaceutical preparations for use in the treatment of pain, inflammation and fever for human use
Filing History
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Jan 29, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 14, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 13, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2026 CNSA
REFUSAL PROCESSED BY IB
Jan 1, 2026 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 5, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 24, 2025 SDRC
